Profile	GDS4460 / 224605_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	533.1	91
GSM803589	patient 7, baseline	810	94
GSM803592	patient 8, baseline	871.5	95
GSM803595	patient 10, baseline	519.4	91
GSM803598	patient 11, baseline	768.8	93
GSM803601	patient 12, baseline	693.9	93
GSM803604	patient 13, baseline	591.3	92
GSM803607	patient 14, baseline	489.5	90
GSM803610	patient 15, baseline	701	93
GSM803613	patient 16, baseline	901.5	94
GSM803587	patient 6, arm treated with pimecrolimus	692.1	93
GSM803590	patient 7, arm treated with pimecrolimus	610.8	92
GSM803593	patient 8, arm treated with pimecrolimus	473.9	89
GSM803605	patient 13, arm treated with pimecrolimus	659.6	92
GSM803608	patient 14, arm treated with pimecrolimus	664.7	92
GSM803599	patient 11, arm treated with pimecrolimus	689.2	93
GSM803611	patient 15, arm treated with pimecrolimus	510.8	90
GSM803614	patient 16, arm treated with pimecrolimus	748.9	93
GSM803602	patient 12, arm treated with pimecrolimus	710.2	93
GSM803596	patient 10, arm treated with pimecrolimus	601.9	92
GSM803591	patient 8, arm treated with betamethasone	758.7	93
GSM803609	patient 15, arm treated with betamethasone	754	94
GSM803597	patient 11, arm treated with betamethasone	773.5	94
GSM803585	patient 6, arm treated with betamethasone	813.7	94
GSM803603	patient 13, arm treated with betamethasone	811.7	94
GSM803612	patient 16, arm treated with betamethasone	967.6	95
GSM803588	patient 7, arm treated with betamethasone	696.1	93
GSM803594	patient 10, arm treated with betamethasone	501.2	90
GSM803600	patient 12, arm treated with betamethasone	1040.3	96
GSM803606	patient 14, arm treated with betamethasone	683.5	93